Full-Time

Software Engineer

Confirmed live in the last 24 hours

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

No salary listed

Senior

Halifax Regional Municipality, NS, Canada

Category
Full-Stack Engineering
Mobile Engineering
Software QA & Testing
Software Engineering
Requirements
  • Bachelor’s degree.
  • Minimum of 5 years of related experience.
  • Developing professional expertise, applies company policies and procedures to resolve a variety of issues.
Responsibilities
  • Build best-in-class, cloud-native and mobile applications that are reliable, scalable, secure and simple to use.
  • Writing code that is optimized for high performance, high availability, and scalability.
  • Creating and executing software development processes that enable us to meet product system requirements.
  • Completing documentation, supporting deployments and maintenance.
  • Performing testing and debugging of applications.
  • Supporting applications in production.
  • Performing routine professional-based activities (early in career).
  • Contributing to and managing projects (mid-career).
  • Providing advice/direction in primary areas of expertise (specialist and expert).
  • Leveraging professional expertise and relationships to contribute to strategy and drive business results (principal).
  • Building productive internal/external working relationships.
  • Occasionally leading the work of project teams and might formally train junior staff.
Desired Qualifications
  • Bachelor’s degree.
  • Minimum of 5 years of related experience.

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed serves patients, healthcare professionals, and caregivers, focusing on improving care and quality of life. Unlike many competitors, ResMed combines device sales with software subscriptions, creating a recurring revenue model. The company's goal is to reduce hospital visits and lower healthcare costs while providing effective solutions for chronic disease management.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing telehealth adoption boosts demand for ResMed's cloud-connected medical devices.
  • The sleep apnea devices market is projected to grow at a 7.8% CAGR until 2030.
  • AI integration in medical devices enhances diagnostic accuracy, benefiting ResMed's platforms.

What critics are saying

  • Emerging wearable tech companies may impact ResMed's market share in sleep diagnostics.
  • Global chip shortage could delay ResMed's product launches and affect revenue.
  • Regulatory scrutiny on data privacy may increase compliance costs for ResMed.

What makes Resmed unique

  • ResMed offers cloud-connected devices for sleep apnea and COPD management.
  • The company provides software platforms enhancing patient care and reducing healthcare costs.
  • ResMed operates in over 120 countries, ensuring a broad global reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

Veye
Apr 24th, 2025
Top ASX Stocks Get a Lift Post Strong Quarters

ResMed was also recognized as one of LexisNexis "Top 100 Global Innovators."

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.

Medtrade
Apr 4th, 2025
Resmed Launches New Home Sleep Apnea Test

SAN DIEGO - Medtrade exhibitor Resmed has launched NightOwl(TM), a new home sleep apnea test (HSAT) that is now available across the United States.

MPO Magazine
Apr 3rd, 2025
Resmed Launches NightOwl Home Sleep Apnea Test

Resmed has launched its NightOwl home sleep apnea test (HSAT) in the U.S.

MarketBeat
Feb 28th, 2025
Proficio Capital Partners LLC Invests $50.36 Million in ResMed Inc. (NYSE:RMD)

Proficio Capital Partners LLC invests $50.36 million in ResMed Inc. (NYSE:RMD).